Kyle T. Helzer
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer Genomics and Diagnostics 6
-
- Protein Degradation and Inhibitors 2
- Genomics and Chromatin Dynamics 2
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Elaine T. Alarid (4 shared papers)Shigeki Miyamoto (1 shared paper)Natalia Solodin (2 shared papers)Shuang G. Zhao (8 shared papers)Nicholas R. Rydzewski (5 shared papers)Martin Sjöström (5 shared papers)Mark B. Meyer (1 shared paper)Mary Szatkowski Ozers (1 shared paper)
- Journals
- npj Genomic Medicine (2 papers)Molecular and Cellular Biology (2 papers)Clinical Cancer Research (1 paper)Journal of Clinical Oncology (1 paper)Journal of Molecular Endocrinology (1 paper)
- Partner nations
- United StatesSwedenFrance
In The Last Decade
Kyle T. Helzer
10 papers receiving 114 citations
Peers
Comparison fields: 5 of 38
- Cancer Research 36
- Oncology 48
- Genetics 35
- Molecular Biology 65
- Toxicology 2
Countries citing papers authored by Kyle T. Helzer
This map shows the geographic impact of Kyle T. Helzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle T. Helzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle T. Helzer more than expected).
Fields of papers citing papers by Kyle T. Helzer
This network shows the impact of papers produced by Kyle T. Helzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle T. Helzer. The network helps show where Kyle T. Helzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle T. Helzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 35 | |
| 2 | 2018 | 22 | |
| 3 | 2021 | 16 | |
| 4 | 2018 | 10 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 0 | |
| 12 | 2024 | 0 |
About Kyle T. Helzer
Kyle T. Helzer is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 114 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (3 papers), Protein Degradation and Inhibitors (2 papers), Genomics and Chromatin Dynamics (2 papers), Estrogen and related hormone effects (2 papers), Computational Drug Discovery Methods (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Cancer Research (36 citations), Oncology (48 citations), Genetics (35 citations), Molecular Biology (65 citations) and Toxicology (2 citations). Kyle T. Helzer has collaborated with scholars based in United States, Sweden and France. Frequent co-authors include Elaine T. Alarid, Shigeki Miyamoto, Natalia Solodin, Shuang G. Zhao, Nicholas R. Rydzewski, Martin Sjöström, Mark B. Meyer, Mary Szatkowski Ozers, Eric J. Small and David A. Quigley. Their work appears in journals such as npj Genomic Medicine, Molecular and Cellular Biology, Clinical Cancer Research, Journal of Clinical Oncology and Journal of Molecular Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.